Search research articles
Contact Us
Filters
Showing results (491-500 of 513) with videos related to
Page
of 52
Sort By:
Molecular Cancer Therapeutics
|
September 28, 2016
Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1
Lawrence J Thomas, Laura Vitale, Thomas O'Neill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
E Van Cutsem, C Twelves, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2018
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer
D E Gerber, L Horn, M Boyer, et al.
Radiology
|
May 1, 1996
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis
D V Patel, E M Holfels, N P Vogel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
L Paz-Ares, E-H Tan, K O'Byrne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2015
Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants
Despina Contopoulos-Ioannidis, Kelsey M Wheeler, Raymund Ramirez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2015
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
A Davidson, A-S Veillard, A Tognela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 24, 2021
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
D Rodríguez-Abreu, S F Powell, M J Hochmair, et al.
Cancer Chemotherapy and Pharmacology
|
June 20, 2006
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)
W Yeo, M Boyer, H C Chung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2019
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
S Peters, U Dafni, M Boyer, et al.
Page
of 52
Search research articles
Search
Showing results (491-500 of 513) with videos related to
Sort By:
Page
of 52
Molecular Cancer Therapeutics
|
September 28, 2016
Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1
Lawrence J Thomas, Laura Vitale, Thomas O'Neill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study
E Van Cutsem, C Twelves, J Cassidy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2018
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer
D E Gerber, L Horn, M Boyer, et al.
Radiology
|
May 1, 1996
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis
D V Patel, E M Holfels, N P Vogel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
L Paz-Ares, E-H Tan, K O'Byrne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 26, 2015
Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants
Despina Contopoulos-Ioannidis, Kelsey M Wheeler, Raymund Ramirez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2015
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial
A Davidson, A-S Veillard, A Tognela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 24, 2021
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
D Rodríguez-Abreu, S F Powell, M J Hochmair, et al.
Cancer Chemotherapy and Pharmacology
|
June 20, 2006
Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)
W Yeo, M Boyer, H C Chung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2019
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
S Peters, U Dafni, M Boyer, et al.
Page
of 52